« Return to News | Awards & Advancement

MS research funding awards given

Wednesday, July 6, 2011 10:13 AM

Merck Serono and Fast Forward announced the second group of recipients to receive funding designed to speed research advances in high potential areas of multiple sclerosis (MS) research.

The awards total over $1 million and will be distributed from two funds created by Merck Serono and Fast Forward to encourage early-stage drug discovery for MS: the Accelerating Commercial Development Fund to develop programs for for-profit entities, and the Accelerating Innovation Fund available to university-based investigators and seed-stage for-profit entities.

Under the Accelerating Innovation Fund the following awards were made:

  • Howard Florey Institute in Australia will receive $275,000 over 12 months to advance the development of molecules that target Nav 1.6 ion channels.
  • The Gladstone Institutes /UCSF will receive $300,000 to conduct testing for the identification of small molecule inhibitors of microglial activation.

The Accelerating Commercial Development Fund made the following award:

  • Axxam of Italy will receive $430,590 over 18 months to advance the development of small molecules that target the sodium-calcium exchanger NCX1 on axons.
Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.